Grassley, Baucus seek information from former drug company executive in Avandia case
WASHINGTON — Sens. Chuck Grassley and Max Baucus have asked a former drug company research executive to provide information to the Senate Committee on Finance about attempts to intimidate a prominent independent scientist who voiced concerns about drug safety.
Dr. Tadataka Yamada was formerly the head of research at GlaxoSmithKline. He now heads the Global Health Program at the Bill and Melinda Gates Foundation. Dr. John Buse was a professor of medicine at the University of North Carolina in 1999, when he expressed concerns about the diabetes drug Avandia, which is made by GlaxoSmithKline.
Next Article Previous Article
- Wyden, Grassley, Finance Committee Members Continue Investigation into U.S. Organ Transplant System
- Wyden and Murray Sound Alarm on Trump Move to Stop Diversity and Inclusion Trainings
- Wyden Blasts Continued Attempts by Senate Republicans to Influence the Election with Bogus Allegations
- Van Hollen, Wyden, Davis Introduce Legislation to Improve Federal Programs to Promote Healthy Relationships and Financial Stability for Low-Income Families
- Wyden Takes to Senate Floor to Pass Enhanced Unemployment Benefits